Superoxide production and LDL oxidation by diabetic neutrophils

Journal of Diabetes and its Complications

Volumn 10, Issue 4, 1996, Pages 206-210

  Fuller, Cindy J ^a   Agil, Ahmad ^a   Lender, Dan ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PHAGOCYTE; PRIORITY JOURNAL;

EID: 0030575289     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/1056-8727(95)00002-X     Document Type: Article

References (16)

1. 1. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992.
2. 2. Lyons TJ: Glycation and oxidation: A role in the pathogenesis of atherosclerosis. Am J Cardiol 71:26B-31B, 1993.
3. 3. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherosclerosis. J Clin Invest 88:1785-1792, 1991.
4. 4. O'Brien R, Timmins K: The role of oxidation and glycation in the pathogenesis of diabetic atherosclerosis. Trends Endocrinol Metab 5:329-334, 1994.
5. 5. Wilson RM: Neutrophil function in diabetes. Diabetic Med 3:509-512, 1986.
6. 6. Cathcart MK, Morel DW, Chisolm GM, III: Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukocyte Biol 38:341-350, 1985.
7. 7. Scaccini C, Jialal I: LDL modification by activated polymorphonuclear leukocytes: A cellular model of mild oxidative stress. Free Radic Biol Med 16:49-55, 1994.
8. 8. Nath N, Chari SN, Rathi AB: Superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes 33:586-589, 1994.
9. 9. Shah SV, Wallin JD, Eilen SD: Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 57:402-409, 1983.
10. 10. Tater D, Tepaut B, Bercovici JP, Youinou P: Polymorphonuclear cell derangements in type I diabetes. Horm Metab Res 19:642-647, 1987.
11. 11. Sullivan K, Raskin P: Evaluation of a new automated affinity chromatographic method for the measurement of glycated hemoglobin. Diabetes Res Clin Pract 13:103-106, 1991.
12. 12. Esterbauer H, Striegl G, Puhl H, et al: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67-75, 1989.
13. 13. Cominacini L, Garbin V, Davoli A, et al.: A simple test for predisposition of LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 32:349-358, 1991.
14. 14. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient? (Atherosclerosis 102:63-67, 1993).
15. 15. Baynes JW: Role of oxidative stress in development of complications of diabetes. Diabetes 40:405-412, 1991.
16. 16. Wolff SP: Diabetes mellitus and free radicals. Br Med Bull 49:642-652, 1993.